Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-Conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. JASRAE 2019, 16 (6), 3589-3595.